Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Lessening the Burden of Familial Hypercholesterolemia Using Health Information Technology.

Safarova MS, Kullo IJ.

Circ Res. 2018 Jan 5;122(1):26-27. doi: 10.1161/CIRCRESAHA.117.312319. No abstract available.

PMID:
29301842
2.

Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis.

Ezhov MV, Afanasieva OI, Il'ina LN, Safarova MS, Adamova IY, Matchin YG, Konovalov GA, Akchurin RS, Pokrovsky SN.

Atheroscler Suppl. 2017 Nov;30:187-192. doi: 10.1016/j.atherosclerosissup.2017.05.011. Epub 2017 May 31.

PMID:
29096836
3.

Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity.

Pokrovsky SN, Afanasieva OI, Safarova MS, Balakhonova TV, Matchin YG, Adamova IYU, Konovalov GA, Ezhov MV.

Atheroscler Suppl. 2017 Nov;30:166-173. doi: 10.1016/j.atherosclerosissup.2017.05.004. Epub 2017 May 31.

PMID:
29096833
4.

[Degenerative Aortic Stenosis: Modern View on Development, Course, and Management].

Burdeinaya AL, Safarova MS, Ezhov MV, Kukharchuk VV.

Kardiologiia. 2016 Jun;56(6):69-74. Russian.

PMID:
28290851
5.

Child-Parent Familial Hypercholesterolemia Screening in Primary Care.

Kullo IJ, Safarova MS.

N Engl J Med. 2017 Feb 2;376(5):498. No abstract available.

PMID:
28150922
6.

Variability in assigning pathogenicity to incidental findings: insights from LDLR sequence linked to the electronic health record in 1013 individuals.

Safarova MS, Klee EW, Baudhuin LM, Winkler EM, Kluge ML, Bielinski SJ, Olson JE, Kullo IJ.

Eur J Hum Genet. 2017 Apr;25(4):410-415. doi: 10.1038/ejhg.2016.193. Epub 2017 Feb 1.

7.

Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study.

Safarova MS, Liu H, Kullo IJ.

J Clin Lipidol. 2016 Sep-Oct;10(5):1230-9. doi: 10.1016/j.jacl.2016.08.001. Epub 2016 Aug 6.

PMID:
27678441
8.

Association of a Family History of Coronary Heart Disease With Initiation of Statin Therapy in Individuals at Intermediate Risk: Post Hoc Analysis of a Randomized Clinical Trial.

Safarova MS, Bailey KR, Kullo IJ.

JAMA Cardiol. 2016 Jun 1;1(3):364-6. doi: 10.1001/jamacardio.2016.0227. No abstract available.

PMID:
27438122
9.

My Approach to the Patient With Familial Hypercholesterolemia.

Safarova MS, Kullo IJ.

Mayo Clin Proc. 2016 Jun;91(6):770-86. doi: 10.1016/j.mayocp.2016.04.013. Review.

10.

[Comparison of Atherosclerotic Lesions in Patients With Acute Myocardial Infarction and Stable Angina Pectoris Using Intravascular Ultrasound].

Tagieva NR, Shakhnovich RM, Mironov YM, Yezhov MV, Matchin YG, Mitroshkin MG, Safarova MS, Shitov VN, Ruda MY.

Kardiologiia. 2015;55(7):5-13. Russian.

PMID:
26688920
11.

[The Evolution of Views on Lipoprotein(a): From Biomarker to the Therapeutic Target].

Safarova MS, Ezhov MV.

Kardiologiia. 2015;55(4):71-82. Review. Russian.

PMID:
26502507
12.

[Conventional and novel cardiovascular risk factors and predisposition to the development of atherosclerosis].

Sobenin IA, Zhelankin AV, Chernova EV, Kirichenko TV, Safarova MS, Sergienko IV, Doroshchuk AD, Trubinov SS, Karagodin VP, Orekhov AN.

Patol Fiziol Eksp Ter. 2015 Jan-Mar;59(1):4-11. Russian.

PMID:
26226683
13.

[Comparison of Atherosclerotic Lesions in Patients With Acute Myocardial Infarction and Stable Angina Pectoris Using Intravascular Ultrasound].

Tagieva NR, Shakhnovich RM, Mironov VM, Yezhov MV, Matchin YG, Mitroshkin MG, Safarova MS, Shitov VN, Ruda MY.

Kardiologiia. 2015 Jul;55(7):5-13. Russian.

PMID:
28294910
14.

[Transcatheter treatment of degenerative critical aortic valve stenosis in a patient with severe heart failure and chronic lymphocytic leukemia].

Safarova MS, Imaev TĒ, Lorie IuIu, Saidova MA, Ezhov MV.

Kardiologiia. 2015;55(1):82-7. Russian.

PMID:
26050498
15.

Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.

Ezhov MV, Safarova MS, Afanasieva OI, Pogorelova OA, Tripoten MI, Adamova IY, Konovalov GA, Balakhonova TV, Pokrovsky SN.

Atheroscler Suppl. 2015 May;18:163-9. doi: 10.1016/j.atherosclerosissup.2015.02.025.

PMID:
25936321
16.

Lowering of lipoprotein(a) level under niacin treatment is dependent on apolipoprotein(a) phenotype.

Artemeva NV, Safarova MS, Ezhov MV, Afanasieva OI, Dmitrieva OA, Pokrovsky SN.

Atheroscler Suppl. 2015 May;18:53-8. doi: 10.1016/j.atherosclerosissup.2015.02.008.

PMID:
25936305
17.

[Evolution of Lipoprotein(a): From Biomarker to the Therapeutic Target].

Safarova MS, Ezhov MV.

Kardiologiia. 2015 Apr;55(4):71-82. Russian.

PMID:
28294902
18.

[Transcatheter Treatment of Degenerative Critical Aortic Valve Stenosis in a Patient With Severe Heart Failure and Chronic Lymphocytic Leukemia].

Safarova MS, Imaev TE, Lorie YY, Saidova MA, Ezhov MV.

Kardiologiia. 2015 Jan;55(1):82-87. Russian.

PMID:
28294834
19.

Variance in niacin response in individuals with elevated lipoprotein(a).

Safarova MS, Ezhov MV.

J Clin Lipidol. 2014 Nov-Dec;8(6):646-7. doi: 10.1016/j.jacl.2014.08.007. Epub 2014 Sep 2. No abstract available.

PMID:
25499949
20.

Dramatic fate of a young coronary heart disease patient rescued with specific lipoprotein(a) apheresis.

Safarova MS, Ezhov MV, Afanasieva OI, Konovalov GA, Pokrovsky SN.

J Clin Apher. 2015 Jun;30(3):193-5. doi: 10.1002/jca.21356. Epub 2014 Sep 2.

PMID:
25181645
21.

[Effect of cascade plasma filtration on spectrum of subfractions of low density lipoproteins in blood plasma of patients with ischemic heart disease].

Utkina EA, Afanas'eva OI, Adamova IIu, Ezhov MV, Safarova MS, Artem'eva NV, Adzhiev RN, Pokrovskiĭ SN.

Kardiologiia. 2014;54(4):10-5. Russian.

PMID:
25177780
22.

Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting.

Ezhov MV, Safarova MS, Afanasieva OI, Kukharchuk VV, Pokrovsky SN.

Atherosclerosis. 2014 Aug;235(2):477-82. doi: 10.1016/j.atherosclerosis.2014.05.944. Epub 2014 Jun 4.

PMID:
24952151
23.

Ig apheresis for the treatment of severe DCM patients.

Pokrovsky SN, Ezhov MV, Safarova MS, Saidova MA, Shitov VN, Afanasieva MI, Khaustov AI, Adamova IY, Afanasieva OI, Konovalov GA.

Atheroscler Suppl. 2013 Jan;14(1):213-8. doi: 10.1016/j.atherosclerosissup.2012.10.028.

PMID:
23357167
24.

Cascade plasma filtration during the first year after CABG in patients with hyperlipidemia refractory to statins.

Ezhov MV, Il'ina LN, Safarova MS, Afanasieva OI, Adamova IY, Atanesyan RV, Konovalov GA, Akchurin RS, Pokrovsky SN.

Atheroscler Suppl. 2013 Jan;14(1):101-5. doi: 10.1016/j.atherosclerosissup.2012.10.014.

PMID:
23357150
25.

Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography.

Safarova MS, Ezhov MV, Afanasieva OI, Matchin YG, Atanesyan RV, Adamova IY, Utkina EA, Konovalov GA, Pokrovsky SN.

Atheroscler Suppl. 2013 Jan;14(1):93-9. doi: 10.1016/j.atherosclerosissup.2012.10.015.

PMID:
23357149
26.

Images in clinical medicine. A head shot.

Safarova MS, Ezhov MV.

N Engl J Med. 2011 Dec 29;365(26):2519. doi: 10.1056/NEJMicm1009118. No abstract available.

27.

[Value of the spectral analysis of radiofrequency intravascular ultrasound data in the evaluation of nonsignificant coronary lesions in chronic CHD patients].

Mitroshkin MG, Ezhov MV, Matchin IuG, Safarova MS, Soboleva DI, Dotsenko IuV.

Kardiologiia. 2011;51(10):4-8. Russian.

PMID:
22117674
28.

[Pleiotropic effects of nicotinic acid therapy in men with coronary heart disease and elevated lipoprotein(a) levels].

Safarova MS, Trukhacheva EP, Ezhov MV, Afanas'eva OI, Afanas'eva MI, Tripoten' MI, Liakishev AA, Pokrovskiĭ SN.

Kardiologiia. 2011;51(5):9-16. Russian.

PMID:
21649590

Supplemental Content

Loading ...
Support Center